Why Ericsson Shares Are Trading Lower? Here Are 56 Stocks Moving In Thursday's Mid-Day Session
$ACOR
$ALF
$ALL
$APCX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Property-Casualty Insurers
Finance
Gainers
- NextPlay Technologies, Inc. (NASDAQ:NXTP) shares jumped 126% to $0.4525 after the company announced its NextFintech division received commitment for a $15 million strategic investment.
- Ascent Solar Technologies, Inc. (NASDAQ:ASTI) gained 44.1% to $4.6852. Ascent Solar recently named Jeffrey Max as CEO.
- American Rebel Holdings, Inc. (NASDAQ:AREB) rose 32.4% to $0.3640 after the company announced it sees $5 million in pro forma Q3 gross revenue.
- Alfi, Inc. (NASDAQ:ALF) jumped 30.8% to $0.3390.
- Rubicon Technologies, Inc. (NYSE:RBT) gained 30.3% to $2.5790.
- NGM Biopharmaceuticals, Inc. (NASDAQ:NGM) rose 26% to $4.65. NGM Biopharmaceuticals Director David Goeddel V bought a total of 130,000 shares at an average price of $3.56.
- Cabaletta Bio, Inc. (NASDAQ:CABA) jumped 24% to $1.62. Cabaletta Bio President and CEO Steven Nichtberger acquired a total of 8,127 shares at an average price of $1.25.
- AppTech Payments Corp. (NASDAQ:APCX) rose 23.3% to $0.7459.
- Skillz Inc. (NYSE:SKLZ) gained 22.6% to $1.08. Skillz is expected to release its Q3 results after the close of the market on Wednesday, November 2, 2022.
- Polished.com Inc. (NYSE:POL) rose 21.1% to $0.63.
- Invivyd, Inc. (NASDAQ:IVVD) jumped 19.9% to $3.91. Invivyd recently appointed Fred Driscoll as interim Chief Financial Officer.
- MicroCloud Hologram Inc. (NASDAQ:HOLO) gained 19.5% to $2.93.
- VolitionRx Limited (NASDAQ:VNRX) gained 19.3% to $1.73. Volition signed global supply agreement for Nu.Q Vet Cancer Test.
- PaxMedica, Inc. (NASDAQ:PXMD) jumped 18.8% to $3.2108.
- Telos Corporation (NASDAQ:TLS) shares climbed 18.8% to $9.94. Needham maintained Telos with a Buy and raised the price target from $10 to $13.
- PDS Biotechnology Corporation (NASDAQ:PDSB) surged 18% to $4.77. PDS Biotech recently announced expanded interim data in the Phase 2 clinical trial investigating the PDS0101-based triple combination therapy.
- NVE Corporation (NASDAQ:NVEC) rose 17.9% to $56.86. NVE posted Q2 EPS of $1.26.
- COMSovereign Holding Corp. (NASDAQ:COMS) gained 17.9% to $0.1035 after dipping 26% on Wednesday. COMSovereign recently announced receipt of Nasdaq listing determination.
- Vertiv Holdings Co (NYSE:VRT) surged 15% to $13.11 following a Bloomberg report suggesting Starboard Value took a stake in the company.
- Monarch Casino & Resort, Inc. (NASDAQ:MCRI) gained 14.5% to $70.50. Stifel upgraded Monarch Casino & Resort from Hold to Buy and raised the price target from $70 to $77.
- Super Micro Computer, Inc. (NASDAQ:SMCI) shares gained 13.2% to $62.91 after the company raised Q1 net sales guidance and adjusted EPS guidance above estimates.
- Pineapple Energy Inc. (NASDAQ:PEGY) rose 13% to $4.2946 after dipping over 20% on Wednesday.
- Mullen Automotive, Inc. (NASDAQ:MULN) rose 12% to $0.3808. Mullen Automotive shares jumped 57% on Wednesday after the company announced US Bankruptcy Court approval of its acquisition of ELMS assets.
- Bright Health Group, Inc. (NYSE:BHG) climbed 11.4% to $1.07.
- Kaiser Aluminum Corporation (NASDAQ:KALU) gained 11.2% to $74.47 after the company reported better-than-expected Q3 sales results.
- Enservco Corporation (NYSE:ENSV) rose 6.1% to $1.4325 after the company swung to a profit in the first quarter.
- International Business Machines Corporation (NYSE:IBM) shares rose 4.3% to $127.82 after the company reported better-than-expected Q3 EPS and sales results.
Losers
- Talaris Therapeutics, Inc. (NASDAQ:TALS) shares dipped 41.9% to $1.4050 after the company announced it received a report of a patient death, which triggered a pre-specified, temporary stopping requirement and review by the FREEDOM-1 Data Monitoring Committee.
- LMF Acquisition Opportunities, Inc. (NASDAQ:LMAO) fell 24.6% to $7.85. LMF Acquisition Opportunities recently announced stockholders approved the previously-announced business combination with SeaStar Medical.
- PARTS iD, Inc. (NYSE:ID) dropped 20.8% to $1.3699.
- SenesTech, Inc. (NASDAQ:SNES) declined 20.6% to $0.2701.
- Scopus BioPharma Inc. (NASDAQ:SCPS) dipped 19.9% to $0.2979. Scopus BioPharma on Tuesday announced the completion of its recapitalization.
- Stabilis Solutions, Inc. (NASDAQ:SLNG) dropped 19% to $8.17.
- Helbiz, Inc. (NASDAQ:HLBZ) dropped 18.6% to $0.2767.
- Rumble Inc. (NASDAQ:RUM) fell 18.3% to $6.66 after The Bear Cave issued a cautious report on the stock.
- Kala Pharmaceuticals, Inc. (NASDAQ:KALA) dropped 18% to $0.1927. Kala Pharmaceuticals announced a 1-for-50 reverse stock split, effective 4:05 p.m. Oct. 20.
- Zovio Inc (NASDAQ:ZVO) shares fell 16% to $0.1764 after gaining 5% on Wednesday.
- Mana Capital Acquisition Corp. (NASDAQ:MAAQ) declined 15.8% to $8.50.
- Fulcrum Therapeutics, Inc. (NASDAQ:FULC) dropped 15.5% to $5.51.
- First Internet Bancorp (NASDAQ:INBK) fell 15.4% to $26.06 following downbeat quarterly earnings.
- Concord Medical Services Holdings Limited (NYSE:CCM) dipped 14.6% to $1.35.
- Telefonaktiebolaget LM Ericsson (NASDAQ:ERIC) fell 14.4% to $5.49 after the company reported mixed Q3 earnings results.
- Calliditas Therapeutics AB (NASDAQ:CALT) dropped 11.7% to $12.00.
- Heritage-Crystal Clean, Inc (NASDAQ:HCCI) fell 11.7% to $28.53. Heritage-Crystal Clean posted Q3 EPS of $1.01.
- The Allstate Corporation (NYSE:ALL) dropped 11.5% to $119.57 after the company announced estimated results for Q3'22 of a net loss between $675 million and $725 million.
- Amprius Technologies, Inc. (NASDAQ:AMPX) fell 11.1% to $9.78. Amprius Technologies shares jumped 77% on Wednesday after the company announced it was awarded a $50 million cost-sharing grant from the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains.
- RedHill Biopharma Ltd. (NASDAQ:RDHL) shares fell 10.4% to $0.6090. RedHill Biopharma shares jumped around 47% on Wednesday after the company announced its oral broad-acting antiviral, Opaganib, was granted a new COVID-19 treatment patent.
- WD-40 Company (NASDAQ:WDFC) dropped 9.8% to $154.01 after the company reported worse-than-expected Q4 EPS and sales results. The company also issued FY23 EPS guidance below analyst estimates.
- Kintara Therapeutics, Inc. (NASDAQ:KTRA) shares fell 9.5% to $0.1091 after gaining over 20% on Wednesday. The company announced it paused its REM-001 program to conserve funds to support its VAL-083 international registrational study.
- Triumph Bancorp, Inc. (NASDAQ:TBK) fell 8.7% to $49.72 after the company reported worse-than-expected Q3 EPS and sales results.
- Trupanion, Inc. (NASDAQ:TRUP) dropped 8.3% to $48.05.
- Synovus Financial Corp. (NYSE:SNV) fell 7.8% to $38.08 following Q3 results.
- Acorda Therapeutics, Inc. (NASDAQ:ACOR) fell 7.5% to $0.5377 after dipping 20% on Wednesday. Acorda Therapeutics recently announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
- The Western Union Company (NYSE:WU) dropped 6.8% to $13.27. The company said it sees FY22 adjusted EPS of $1.75-$1.85.
- Nokia Oyj (NYSE:NOK) shares fell 6.3% to $4.2750 after reporting Q3 earnings.
- Tesla, Inc. (NASDAQ:TSLA) fell 4.8% to $211.44. Tesla reported better-than-expected earnings for its third quarter, while sales missed estimates. The company also reported a year over year decrease in Q3 total deliveries.